Distribution margin dispute draws keen attention from drug industry

As the distribution profit margin feud flares up between wholesalers and Bayer Korea, Korean drug firms and multination firms are watching the progress with a keen interest.

If Bayer Korea gains ground in the battle, other foreign drug manufacturers will follow suit amid worsening profitability.

For their part, Korean drug companies have so far provided a wholesaler with generous margins ...